FTC drops challenge to Philadelphia health system merger

The Federal Trade Commission is no longer challenging the merger between Jefferson Health and Einstein Healthcare Network, clearing the way for the two Philadelphia-based health systems to combine. 

Advertisement

The FTC dropped its challenge to the transaction Feb. 26 after previously arguing that the combination of the two systems would reduce competition in Philadelphia and Montgomery counties and lead to price increases. 

The merger, which will expand Jefferson from 14 to 18 hospitals, is expected to close within the next six months, said Stephen Klasko, MD, president of Thomas Jefferson University and CEO of Jefferson Health. 

“Two nonprofit, anchor institutions coming together to preserve access to care and do the right thing by the residents of Philadelphia is a creative solution to ensure Einstein doesn’t face the same fate as Hahnemann University Hospital,” said Dr. Klasko. “It’s a milestone victory for the city of Philadelphia and for those patients and families we proudly serve.”

Hahnemann University Hospital in Philadelphia closed in 2019 after filing for bankruptcy.

More articles on healthcare industry transactions:
Georgia health systems drop plan to combine
HCA to acquire 80% stake in Brookdale home health, hospice unit for $400M
Ohio health system finalizes deal for 4th hospital

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.